This inventor holds 1 USPTO granted patent. Top assignee: Novartis Vaccines & Diagnostics, Gmbh. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Hans-Peter Guler
Introduction
Hans-Peter Guler is a notable inventor based in Rye, NY (US). He has made significant contributions to the field of medical treatments, particularly in addressing articular cartilage disorders. His innovative approach has the potential to improve the quality of life for many individuals suffering from conditions such as osteoarthritis.
Latest Patents
Hans-Peter Guler holds a patent for "Compositions and methods for treating articular cartilage disorders." This patent outlines a method for treating mammalian articular cartilage disorders, specifically targeting osteoarthritis and trauma-related cartilage injuries. The method involves increasing the amount of insulin-like growth factor I (IGF-I) at the affected site to a therapeutically effective level. This approach aims to maintain and regenerate cartilage, which is crucial for the long-term treatment of these conditions. The patent details that single doses of at least 0.01 mg of pharmaceutically effective IGF-I should be administered intermittently, with a recommended frequency of about once per week or less.
Career Highlights
Hans-Peter Guler is associated with Novartis Vaccines & Diagnostics GmbH, where he continues to work on innovative solutions in the medical field. His expertise and dedication to research have positioned him as a valuable asset in the development of treatments for cartilage disorders.
Collaborations
Throughout his career, Hans-Peter Guler has collaborated with esteemed colleagues, including Marilyn C. Pike and Grushenka H. I. Wolfgang. These collaborations have fostered a productive environment for innovation and advancement in medical research.
Conclusion
Hans-Peter Guler's contributions to the treatment of articular cartilage disorders exemplify the impact of innovative thinking in medicine. His work not only highlights the importance of research and development but also offers hope for improved therapies for those affected by cartilage-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile